₹3,281.90
−0.59%NSE close, 16 Nov 2026
−29.22%
Sanofi India is a small cap company, listed on NSE under the symbol SANOFI. At ₹3,281.90 a share, the market values the whole company at ₹7,558 crore.
In Dec 2025, it reported sales of ₹1,837 crore and a net profit of ₹327 crore, an operating margin of 26.7%. Over the last three years, sales fell 14.7% a year and net profit fell 29.8% a year.
The market values the company at 20.7 times its profit over the last twelve months and 9.15 times its book value; its return on equity is 44.1% and it has almost no borrowings.
Promoters hold 60.40% of the shares. Foreign institutions hold 5.73%, and domestic institutions, mutual funds among them, 19.41%.
Over the past year the share price has fallen 30.9%, and it is 30.0% below its 52-week high.
₹ crore. Consolidated figures where the company filed them, standalone otherwise (marked S).
| Line | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 S | Jun 2025 S | Sep 2025 S |
|---|
Communication of Tax Deduction at Source on Interim Dividend for the Financial Year 2026
Board of Directors at its meeting held on October 29, 2026, declared Interim Dividend of Rs. 75 per equity share.
Record date for the purpose of Dividend is 05-Nov-2026.
Sanofi India delivers strong Q3 2026 performance, led by 9% growth in Diabetes Portfolio resulting in robust profit momentum
| Dec 2025 S |
|---|
| Mar 2026 S |
|---|
| Jun 2026 S |
|---|
| Sep 2026 S |
|---|
| Sales | 694 | 732 | 464 | 524 | 515 | 536 | 406 | 475 | 420 | 472 | 438 | 492 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | 507 | 514 | 348 | 404 | 397 | 364 | 311 | 341 | 330 | 330 | 322 | 331 |
| Operating profit | 187 | 219 | 116 | 120 | 118 | 172 | 94.9 | 134 | 90.3 | 143 | 115 | 161 |
| Operating margin | 27.0% | 29.9% | 25.0% | 22.8% | 23.0% | 32.1% | 23.4% | 28.2% | 21.5% | 30.2% | 26.3% | 32.8% |
| Other income | 12.0 | 6.5 | 4.8 | 2.3 | 5.9 | 3.3 | 8.7 | 4.9 | 2.8 | 4.4 | 6.2 | 5.5 |
| Interest | 0.4 | 0.3 | 0.4 | 0.4 | 0.4 | 0.3 | 0.4 | 0.4 | 0.6 | 0.3 | 0.3 | 0.2 |
| Depreciation | 10.2 | 10.0 | 9.0 | 9.0 | 9.6 | 9.6 | 9.1 | 9.1 | 9.5 | 9.0 | 8.9 | 8.8 |
| Profit before tax | 189 | 188 | 92.1 | 113 | 122 | 165 | 94.1 | 102 | 83.0 | 138 | 112 | 158 |
| Tax | 51.1 | 51.8 | 23.9 | 30.4 | 30.9 | 45.8 | 24.6 | 26.3 | 21.3 | 35.3 | 28.8 | 41.0 |
| Net profit | 138 | 137 | 103 | 82.2 | 91.3 | 120 | 69.5 | 76.0 | 61.7 | 103 | 83.5 | 117 |
| EPS (₹) | 59.79 | 59.31 | 44.81 | 35.69 | 39.64 | 51.89 | 30.18 | 32.99 | 26.79 | 44.55 | 36.26 | 50.67 |
₹ crore, financial years to Dec.
| Line | Dec 2018 S | Dec 2019 S | Dec 2020 S | Dec 2021 S | Dec 2022 S | Dec 2024 | Dec 2025 S |
|---|---|---|---|---|---|---|---|
| Sales | 2,771 | 3,071 | 2,902 | 2,957 | 2,770 | 2,235 | 1,837 |
| Expenses | 2,147 | 2,405 | 2,189 | 2,194 | 2,066 | 1,662 | 1,346 |
| Operating profit | 624 | 665 | 713 | 763 | 704 | 573 | 491 |
| Operating margin | 22.5% | 21.7% | 24.6% | 25.8% | 25.4% | 25.6% | 26.7% |
| Other income | 89.7 | 94.1 | 89.8 | 74.4 | 71.5 | 19.5 | 19.7 |
| Interest | 0.7 | 0.3 | 1.8 | 1.8 | 1.7 | 1.5 | 1.7 |
| Depreciation | 103 | 99.9 | 82.2 | 66.7 | 41.9 | 37.6 | 37.3 |
| Profit before tax | 610 | 600 | 677 | 1,258 | 864 | 515 | 445 |
| Tax | 229 | 186 | 200 | 313 | 244 | 137 | 118 |
| Net profit | 381 | 414 | 478 | 944 | 621 | 413 | 327 |
| EPS (₹) | 165.48 | 179.85 | 207.38 | 410.06 | 269.47 | 179.45 | 141.85 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | Dec 2021 | Dec 2025 | 6M to Jun 2026 |
|---|---|---|---|
| From operations | 559 | 438 | 211 |
| From investing | 631 | −11.3 | −2.3 |
| From financing | −849 | −448 | −113 |
| Spent on fixed assets | −23.0 | −25.7 | −10.5 |
| Free cash flow | 536 | 413 | 201 |
Margins, returns, debt, tax and cash.
| Line | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Net margin | 13.7% | 13.5% | 16.5% | 31.9% | 22.4% | 18.5% | 17.8% |
| Operating margin | 22.5% | 21.7% | 24.6% | 25.8% | 25.4% | 25.6% | 26.7% |
| Return on equity | – | – | – | – | 48.6% | 48.0% | 43.6% |
| Return on capital employed | – | – | – | – | 67.9% | 60.0% | 59.6% |
| Return on assets | – | – | – | – | 30.0% | 25.6% | 26.0% |
| Debt to equity | – | – | – | – | 0.00 | 0.00 | 0.00 |
| Interest coverage | 872.10 | 2,000.70 | 377.20 | 699.70 | 509.40 | 344.50 | 262.60 |
| Debt to assets | – | – | – | – | 0.00 | 0.00 | 0.00 |
| Current ratio | – | – | – | – | 2.18 | 1.76 | 1.88 |
| Quick ratio | – | – | – | – | – | 1.06 | 1.24 |
| Cash ratio | – | – | – | – | 1.36 | 0.39 | 0.54 |
| Asset turnover | – | – | – | – | 1.34 | 1.39 | 1.46 |
| Fixed asset turnover | – | – | – | – | 9.08 | 8.74 | 6.06 |
| Inventory turnover | – | – | – | – | – | 2.10 | 2.90 |
| Receivables turnover | – | – | – | – | – | 9.70 | 10.40 |
| Gross margin | – | – | – | – | – | 53.5% | 51.2% |
| Cash from operations to profit | – | – | – | 59.0% | – | – | 134.0% |
| Effective tax rate | 37.6% | 31.0% | 29.5% | 24.9% | 28.2% | 26.6% | 26.5% |
The unaudited financial results for the quarter and nine months ended 30th September 2026.
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Receipt of Show Cause Notice from GST Authority.
A copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011.
Disclosure received by the Company on 25th September 2026 under Regulation 7(2)(a) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 from Sanofi Healthcare India Private Limited, an entity of the Promoter Group of the Company
Disclosure Under Regulation 7(2)(B) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Receipt of Show Cause Notice from GST Authorities
Disclosure Under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
A copy of Disclosure under Regulation 10 (5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( SEBI (LODR) Regulations )
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Receipt of Show Cause Notice from GST Authorities
Please find enclosed intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015